U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 20:38:26 GMT 2025
Edited
by admin
on Mon Mar 31 20:38:26 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
O8R9U9ZUVN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ABT-308
Preferred Name English
CENDAKIMAB
USAN   INN  
Official Name English
HUMANIZED ANTI-HUMAN IL-13 MONOCLONAL ANTIBODY
Common Name English
IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER
Systematic Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL-13 (INTERLEUKIN 13, IL-13)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-453) (VH (HOMO SAPIENS IGHV2-5*08 (80.6%) -(IGHD) -IGHJ4*01 (100%)) (10.7.15) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G
Systematic Name English
Cendakimab [WHO-DD]
Common Name English
CENDAKIMAB [USAN]
Common Name English
RPC-4046
Code English
CC-93538
Code English
cendakimab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 443314
Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025
Code System Code Type Description
SMS_ID
300000005882
Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025
PRIMARY
INN
10990
Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025
PRIMARY
USAN
HI-139
Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025
PRIMARY
NCI_THESAURUS
C174792
Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025
PRIMARY
CAS
2151032-62-9
Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025
PRIMARY
FDA UNII
O8R9U9ZUVN
Created by admin on Mon Mar 31 20:38:26 GMT 2025 , Edited by admin on Mon Mar 31 20:38:26 GMT 2025
PRIMARY
From To
1_22 1_97
2_22 2_97
1_150 1_206
2_150 2_206
1_226 3_214
2_226 4_214
1_232 2_232
1_235 2_235
1_267 1_327
1_373 1_431
2_267 2_327
2_373 2_431
3_23 3_88
4_23 4_88
3_134 3_194
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_303
N 2_303
Related Record Type Details
HUMAN INTERLEUKIN 13
TARGET -> INHIBITOR
Related Record Type Details
CENDAKIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:FORMULA CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966